BioCryst presents successful data from proof-of-concept trial of BCX-9930 in PNH March 23, 2021 No Comments
Cellphire initiates phase II study of Thrombosomes for bleeding in patients with thrombocytopenia March 22, 2021 No Comments
Dosing begins in first-in-human study of CAN-106 for complement dysregulation diseases March 10, 2021 No Comments
FDA accepts IND application for EP-7041 for thrombosis prevention in patients with COVID-19 March 4, 2021 No Comments
Initiation of phase IIa study evaluating BGE-117 in elderly with unexplained anemia Feb. 26, 2021 No Comments
RSS